Steroid Use Independently Predicts for Poor Outcomes in Patients With Advanced NSCLC and High PD-L1 Expression Receiving First-Line Pembrolizumab Monotherapy
Titel:
Steroid Use Independently Predicts for Poor Outcomes in Patients With Advanced NSCLC and High PD-L1 Expression Receiving First-Line Pembrolizumab Monotherapy
Auteur:
Mountzios, Giannis de Toma, Alessandro Economopoulou, Panagiota Friedlaender, Alex Banini, Marco Lo Russo, Giuseppe Baxevanos, Panagiotis Roila, Fausto Banna, Giuseppe Luigi Christopoulou, Athina Jimenez, Beatriz Collazo-Lorduy, Ana Linardou, Helena Calles, Antonio Galetta, Domenico Addeo, Alfredo Camerini, Andrea Pizzutilo, Pamela Kosmidis, Paris Garassino, Marina Chiara Proto, Claudia Signorelli, Diego Metro, Giulio